Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice-Reference-Cited by-同舟云学术

Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice

Published:2009-03-19 Issue:1 Volume:50 Page:85-93
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Zhao Hongmei,Przybylska Malgorzata,Wu I-Huan,Zhang Jinhua,Maniatis Panagiotis,Pacheco Joshua,Piepenhagen Peter,Copeland Diane,Arbeeny Cynthia,Shayman James A.,Aerts Johannes M.,Jiang Canwen,Cheng Seng H.,Yew Nelson S.

Publisher

Wiley

Subject

Hepatology

Reference31 articles.

1. Nonalcoholic fatty liver disease;Adams;CMAJ,2005

2. Nonalcoholic fatty liver disease: from pathogenesis to patient care;Perlemuter;Nat Clin Pract Endocrinol Metab,2007

3. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population;Szczepaniak;Am J Physiol Endocrinol Metab,2005

4. The obesity epidemic and nonalcoholic fatty liver disease in children;Dunn;Curr Gastroenterol Rep,2008

5. Molecular mediators of hepatic steatosis and liver injury;Browning;J Clin Invest,2004

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B3galt5 functions as a PXR target gene and regulates obesity and insulin resistance by maintaining intestinal integrity;Nature Communications;2024-07-14

2. Ceramides are fuel gauges on the drive to cardiometabolic disease;Physiological Reviews;2024-07-01

3. Ligand Activation of the Aryl Hydrocarbon Receptor Upregulates Epidermal Uridine Diphosphate Glucose Ceramide Glucosyltransferase and Glucosylceramides;Journal of Investigative Dermatology;2023-10

4. Sphingomyelin synthase–related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease;Journal of Biological Chemistry;2023-09

5. Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition;Redox Biology;2023-07